BindingDB logo
myBDB logout

BDBM322087 1-{1-(4-fluorobenzyl)-5-[(2-fluorobenzyl)oxy]-1H-pyrazol-3-yl}-N-methylmethanamine::US10183913, Example 218

SMILES: CNCc1cc(OCc2ccccc2F)n(Cc2ccc(F)cc2)n1

InChI Key: InChIKey=DMQJRQHOBCDMGX-UHFFFAOYSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 322087   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Sodium-dependent serotonin transporter


(Homo sapiens (Human))
BDBM322087
PNG
(1-{1-(4-fluorobenzyl)-5-[(2-fluorobenzyl)oxy]-1H-p...)
Show SMILES CNCc1cc(OCc2ccccc2F)n(Cc2ccc(F)cc2)n1
Show InChI InChI=1S/C19H19F2N3O/c1-22-11-17-10-19(25-13-15-4-2-3-5-18(15)21)24(23-17)12-14-6-8-16(20)9-7-14/h2-10,22H,11-13H2,1H3
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
9.70n/an/an/an/an/an/an/an/a



SUMITOMO DAINIPPON PHARMA CO., LTD.

US Patent


Assay Description
The [3H] citalopram binding was measured according to the method disclosed in Owens M. J. et al., J. Pharm. Exp. Ther., 283, 1305-1322 (1997). In spe...


US Patent US10183913 (2019)


BindingDB Entry DOI: 10.7270/Q2MW2K73
More data for this
Ligand-Target Pair
5-hydroxytryptamine receptor 2C


(Homo sapiens (Human))
BDBM322087
PNG
(1-{1-(4-fluorobenzyl)-5-[(2-fluorobenzyl)oxy]-1H-p...)
Show SMILES CNCc1cc(OCc2ccccc2F)n(Cc2ccc(F)cc2)n1
Show InChI InChI=1S/C19H19F2N3O/c1-22-11-17-10-19(25-13-15-4-2-3-5-18(15)21)24(23-17)12-14-6-8-16(20)9-7-14/h2-10,22H,11-13H2,1H3
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
10n/an/an/an/an/an/an/an/a



SUMITOMO DAINIPPON PHARMA CO., LTD.

US Patent


Assay Description
A solution of 200 μL in total was prepared by mixing 50 μL of [3H] mesulergine (manufactured by GE Healthcare) diluted with 50 mmol/L Tris-...


US Patent US10183913 (2019)


BindingDB Entry DOI: 10.7270/Q2MW2K73
More data for this
Ligand-Target Pair